209 related articles for article (PubMed ID: 2593236)
1. [Coagulation and fibrinolysis associated with contact phase in plasma with high molecular weight kininogen deficiency].
Iijima K; Nakamura K
Rinsho Ketsueki; 1989 Oct; 30(10):1702-7. PubMed ID: 2593236
[TBL] [Abstract][Full Text] [Related]
2. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
[TBL] [Abstract][Full Text] [Related]
3. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
4. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
Revak SD; Cochrane CG; Griffin JH
J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
[TBL] [Abstract][Full Text] [Related]
5. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
Lämmle B; Berrettini M; Griffin JH
Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
[TBL] [Abstract][Full Text] [Related]
6. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
[TBL] [Abstract][Full Text] [Related]
7. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
Donaldson VH; Kleniewski J; Saito H; Sayed JK
J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
[TBL] [Abstract][Full Text] [Related]
8. Contact-activated fibrinolysis: role of surface concentration and high-molecular-weight kininogen.
Goldsmith GH
J Lab Clin Med; 1980 Aug; 96(2):222-31. PubMed ID: 7400661
[TBL] [Abstract][Full Text] [Related]
9. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn.
Gordon EM; Ratnoff OD; Saito H; Gross S; Jones PK
Am J Pediatr Hematol Oncol; 1980; 2(3):213-6. PubMed ID: 7435882
[TBL] [Abstract][Full Text] [Related]
10. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
[TBL] [Abstract][Full Text] [Related]
11. New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion.
Vicente V; Alberca I; Gonzalez R; Alegre A; Redondo C; Moro J
Haematologia (Budap); 1986; 19(1):41-8. PubMed ID: 3636267
[TBL] [Abstract][Full Text] [Related]
12. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
13. Prekallikrein (Fletcher factor) deficiency.
Sollo DG; Saleem A
Ann Clin Lab Sci; 1985; 15(4):279-85. PubMed ID: 3849948
[TBL] [Abstract][Full Text] [Related]
14. Practical approach to anticoagulation for cardiopulmonary bypass in the patient with congenital prolonged activated partial thromboplastin time.
Cankovic L; Steenwyk BL; McGiffin DC; Nielsen VG
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):725-6. PubMed ID: 18832918
[TBL] [Abstract][Full Text] [Related]
15. Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock.
Hack CE; Wagstaff J; Strack van Schijndel RJ; Eerenberg AJ; Pinedo HM; Thijs LG; Nuijens JH
Thromb Haemost; 1991 May; 65(5):497-503. PubMed ID: 1871710
[TBL] [Abstract][Full Text] [Related]
16. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.
Kaplan AP
Prog Hemost Thromb; 1978; 4():127-75. PubMed ID: 362477
[No Abstract] [Full Text] [Related]
17. Prekallikrein deficiency in a family of miniature horses.
Turrentine MA; Sculley PW; Green EM; Johnson GS
Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551
[TBL] [Abstract][Full Text] [Related]
18. Prekallikrein, HMW-kininogen and factor XII in various disease states.
Deutsch E; Dragosics B; Kopsa H; Mannhalter C; Rainer H
Thromb Res; 1983 Jul; 31(2):351-64. PubMed ID: 6356459
[TBL] [Abstract][Full Text] [Related]
19. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease.
Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Balsano F
J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088
[TBL] [Abstract][Full Text] [Related]
20. Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors.
Park S; Gu JY; Kim HK
J Thromb Thrombolysis; 2022 Jul; 54(1):11-14. PubMed ID: 34993714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
